Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Can we cure hepatitis B virus with novel direct‐acting antivirals?
María Guadalupe Martínez, François Villeret, Barbara Testoni, et al.
Liver International (2020) Vol. 40, Iss. S1, pp. 27-34
Closed Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Natascha Roehlen, Émilie Crouchet, Thomas F. Baumert
Cells (2020) Vol. 9, Iss. 4, pp. 875-875
Open Access | Times Cited: 852
Immunobiology and pathogenesis of hepatitis B virus infection
Matteo Iannacone, Luca G. Guidotti
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 19-32
Closed Access | Times Cited: 344
Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin
Petra Krafčíková, Jan Šilhán, Radim Nencka, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 270
Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug
Alexandre J. Debacker, Jon Voutila, Matthew C. Catley, et al.
Molecular Therapy (2020) Vol. 28, Iss. 8, pp. 1759-1771
Open Access | Times Cited: 253
Structural insights into the HBV receptor and bile acid transporter NTCP
Jae-Hyun Park, Masashi Iwamoto, Ji-Hye Yun, et al.
Nature (2022) Vol. 606, Iss. 7916, pp. 1027-1031
Open Access | Times Cited: 78
HBV-Integration Studies in the Clinic: Role in the Natural History of Infection
Teresa Pollicino, Giuseppe Caminiti
Viruses (2021) Vol. 13, Iss. 3, pp. 368-368
Open Access | Times Cited: 95
CAPUTO TYPE FRACTIONAL OPERATOR APPLIED TO HEPATITIS B SYSTEM
Anwarud Din, Yongjin Li, Abdullahi Yusuf, et al.
Fractals (2021) Vol. 30, Iss. 01
Open Access | Times Cited: 67
Decoding the multifaceted interventions between human sirtuin 2 and dynamic hepatitis B viral proteins to confirm their roles in HBV replication
Zahra Zahid Piracha, Umar Saeed, Irfan Ellahi Piracha, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 13
Open Access | Times Cited: 10
CRISPR-Cas9 Targeting of Hepatitis B Virus Covalently Closed Circular DNA Generates Transcriptionally Active Episomal Variants
María Guadalupe Martínez, Emmanuel Combe, Aurore Inchauspé, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 29
Advances in hepatitis B therapeutics
Vincent Soriano, Pablo Barreiro, Edward R. Cachay, et al.
Therapeutic Advances in Infectious Disease (2020) Vol. 7
Open Access | Times Cited: 40
Progression of Antiviral Agents Targeting Viral Polymerases
Siqi Peng, Huizhen Wang, Zhengtao Wang, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7370-7370
Open Access | Times Cited: 24
Recent Advances in Understanding, Diagnosing, and Treating Hepatitis B Virus Infection
Magda Rybicka, Krzysztof Piotr Bielawski
Microorganisms (2020) Vol. 8, Iss. 9, pp. 1416-1416
Open Access | Times Cited: 33
Molecular elucidation of drug-induced abnormal assemblies of the hepatitis B virus capsid protein by solid-state NMR
Lauriane Lecoq, Louis Brigandat, Rebecca Huber, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure
Ming‐Ling Chang, Yun‐Fan Liaw
Drugs (2023) Vol. 83, Iss. 5, pp. 367-388
Closed Access | Times Cited: 12
Molecular recognition of bio-active triterpenoids from Swertia chirayita towards hepatitis Delta antigen: a mechanism through docking, dynamics simulation, Gibbs free energy landscape
Maheswata Moharana, Subrat Kumar Pattanayak, Fahmida Khan
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 24, pp. 14651-14664
Closed Access | Times Cited: 11
Advances in discovery of novel investigational agents for functional cure of chronic hepatitis B: A comprehensive review of phases II and III therapeutic agents
Robert L. Lam, Joseph K. Lim
World Journal of Hepatology (2024) Vol. 16, Iss. 3, pp. 331-343
Open Access | Times Cited: 4
Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoids
Michael Kirstgen, Kira Alessandra Alicia Theresa Lowjaga, Simon Müller, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 32
Peroxiredoxins—The Underrated Actors during Virus-Induced Oxidative Stress
Inna L. Karpenko, Vladimir T. Valuev-Elliston, Olga N. Ivanova, et al.
Antioxidants (2021) Vol. 10, Iss. 6, pp. 977-977
Open Access | Times Cited: 25
Antiviral Therapy of Chronic Hepatitis B Virus between Present and Future
Mariana Daniela Ignat, Alexia Anastasia Stefania Balta, Raisa Eloise Barbu, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 2055-2055
Open Access | Times Cited: 3
Envelope Proteins of Hepatitis B Virus: Molecular Biology and Involvement in Carcinogenesis
Jun Inoue, Kosuke Sato, Masashi Ninomiya, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1124-1124
Open Access | Times Cited: 23
Fungal Secondary Metabolite Exophillic Acid Selectively Inhibits the Entry of Hepatitis B and D Viruses
Chisa Kobayashi, Yoshihiro Watanabe, Mizuki Oshima, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 764-764
Open Access | Times Cited: 16
Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection
Toshitada Takemori, Akiko Sugimoto-Ishige, Hironori Nishitsuji, et al.
Journal of Virology (2022) Vol. 96, Iss. 5
Open Access | Times Cited: 15
SIRT2 Promotes HBV Transcription and Replication by Targeting Transcription Factor p53 to Increase the Activities of HBV Enhancers and Promoters
Daiqing Wu, Qiuying Ding, Na‐Na Tao, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 15
Improved pharmacokinetics of tenofovir ester prodrugs strengthened the inhibition of HBV replication and the rebalance of hepatocellular metabolism in preclinical models
Xiaodan Hong, Zuhuan Cai, Fang Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Critical Updates on Chronic Hepatitis B Virus Infection in 2021
Cyriac Abby Philips, Rizwan Ahamed, Jinsha K Abduljaleel, et al.
Cureus (2021)
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top